The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27 Kip1 levels by distinct mechanisms

Molecular and Cellular Biology

Volumn 26, Issue 12, 2006, Pages 4612-4627

  Croft, Daniel R ^a   Olson, Michael F ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACTIN; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; ESTROGEN RECEPTOR; HYBRID PROTEIN; LIM KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN ROCK I; PROTEIN ROCK II; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL LINE; CYCLIN A; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FOCAL ADHESIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MICE; MODELS, BIOLOGICAL; NIH 3T3 CELLS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 33745055712     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02061-05     Document Type: Article

References (89)

1. WAF1/CIP1 is Upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase RhoA. Mol. Cell. Biol. 18:6962-6970.
2. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
3. Assoian, R. K., and X. Zhu. 1997. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9:93-98.
4. Auer, K. L., J. S. Park, P. Seth, R. J. Coffey, G. Darlington, A. Abo, M. McMahon, R. A. Depinho, P. B. Fisher, and P. Dent. 1998. Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice. Biochem. J. 336:551-560.
5. Bastow, E. R., K. J. Lamb, J. C. Lewthwaite, A. C. Osborne, E. Kavanagh. C. P. D. Wheeler-Jones, and A. A. Pitsillides. 2005. Selective activation of the MEK-ERK pathway is regulated by mechanical stimuli in forming joints and promotes pericellular matrix formation. J. Biol. Chem. 280:11749-11758.
6. 1/S transition by peripheral cues. Biochem. Pharmacol. 60:1179-1184.
7. Bottazzi, M. E., M. Buzzai, X. Zhu, C. Desdouets, C. Brechot, and R. K. Assoian. 2001. Distinct effects of mitogens and the actin cytoskeleton or CREB and pocket protein phosphorylation control the extent and timing of cyclin A promoter activity. Mol. Cell. Biol. 21:7607-7616.
8. Bubb, M. R., I. Spector, A. D. Bershadsky, and E. D. Korn. 1995. Swinholide A is a microfilament disrupting marine toxin that stabilizes actin dimers and severs actin filaments. J. Biol. Chem. 270:3463-3466.
9. Bubb, M. R., I. Spector, B. B. Beyer, and K. M. Fosen. 2000. Effects of jasplakinolide on the kinetics of actin polymerization. An explanation for certain in vivo observations. J. Biol. Chem. 275:5163-5170.
10. Cechin, S. R., P. R. Dunkley, and R. Rodnight. 2005. Signal transduction mechanisms involved in the proliferation of C6 glioma cells induced by lysophosphatidic acid. Neurochem. Res. 30:603-611.
11. Cheng, T. L., M. Symons, and T. S. Jou. 2004. Regulation of anoikis by Cdc42 and Rac1. Exp. Cell Res. 295:497-511.
12. 1-phase cell-cycle regulation. Nat. Rev. Mol. Cell. Biol. 5:355-366.
13. Waf1/Cip1 protein stability via a cyclin D1-imposed block in proteasome mediated degradation. EMBO J. 22:2036-2046.
14. 1/S cell cycle arrest provides anoikis resistance through Erk-mediated Bim suppression. Mol. Cell. Biol. 25:5282-5291.
15. Coniglio, S. J., T. S. Jou, and M. Symons. 2001. Rac1 protects epithelial cells against anoikis. J. Biol. Chem. 276:28113-28120.
16. Croft, D. R., M. L. Coleman, S. Li, D. Robertson, T. Sullivan, C. L. Stewart, and M. F. Olson. 2005. Actin-myosin-based contraction is responsible for apoptotic nuclear disintegration. J. Cell Biol. 168:245-255.
17. Croft, D. R., and M. F. Olson. 2006. Conditional regulation of a ROCK-estrogen receptor fusion protein. Methods Enzymol. 406:541-553.
18. Croft, D. R., E. Sahai, G. Mavria, S. Li, J. Tsai, W. M. Lee, C. J. Marshall, and M. F. Olson. 2004. Conditional ROCK activation in vivo induces tumor cell dissemination and angiogenesis. Cancer Res. 64:8994-9001.
19. Delaney, A. M., J. A. Printen, H. Chen, E. B. Fauman, and D. T. Dudley. 2002. Identification of a novel mitogen-activated protein kinase kinase activation domain recognized by the inhibitor PD 184352. Mol. Cell. Biol. 22:7593-7602.
20. Gladden, A. B., and J. A. Diehl. 2005. Location, location, location: the role of cyclin D1 nuclear localization in cancer. J. Cell. Biochem. 96:906-913.
21. Gomez del Pulgar, T., S. A. Benitah, P. F. Valeron, C. Espina, and J. C. Lacal. 2005. Rho GTPase expression in tumourigenesis: evidence for a significant link. Bioessays 27:602-613.
22. Guerin, P., V. Sauzeau, M. Rolli-Derkinderen, O. Al Habbash, E. Scalbert, D. Crochet, P. Pacaud, and G. Loirand. 2005. Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycin. J. Vasc. Res. 42: 21-28.
23. Han, S., N. Sidell, and J. Roman. 2005. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett. 219:71-81.
24. Harvey, S. A., S. C. Anderson, and N. SundarRaj. 2004. Downstream effects of ROCK signaling in cultured human corneal stromal cells: microarray analysis of gene expression. Investig. Ophthalmol. Vis. Sci. 45:2168-2176.
25. He, H., J. Pannequin, J. P. Tantiongco, A. Shulkes, and G. S. Baldwin. 2005. Glycine-extended gastrin stimulates cell proliferation and migration through a Rho- and ROCK-dependent pathway, not a Rac/Cdc42-dependent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G478-G488.
26. 1 to S phase in growth-stimulated rat FRTL-5 cells. J. Biol. Chem. 272:13-16.
27. Kip degradation through its regulation of cyclin E/CDK2 activity. J. Biol. Chem. 274:3396-3401.
28. Ishida, K., H. Nagahara, T. Kogiso, T. Aso, N. Hayashi, and T. Akaike. 2003. Cell adhesion aside from integrin system can abrogate anoikis in rat liver cells by down-regulation of FasL expression, not by activation of PI-3K/Akt and ERK signaling pathway. Biochem. Biophys. Res. Commun. 300:201-208.
29. Iso, Y., H. Suzuki, T. Sato, M. Shoji, N. Shimizu, M. Shibata, S. Koba, E. Geshi, and T. Katagiri. 2006. Rho-kinase inhibitor suppressed restenosis in porcine coronary balloon angioplasty. Int. J. Cardiol. 106:103-110.
30. Iwamoto, H., M. Nakamuta, S. Tada, R. Sugimoto, M. Enjoji, and H. Nawata. 2000. A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J. Hepatol. 32:762-770.
31. Kalisch, B. E., C. S. Demeris, M. Ishak, and R. J. Rylett. 2003. Modulation of nerve growth factor-induced activation of MAP kinase in PC12 cells by inhibitors of nitric oxide synthase. J. Neurochem. 87:1321-1332.
32. Kamai, T., K. Arai, S. Sumi, T. Tsujii, M. Honda, T. Yamanishi, and K. I. Yoshida. 2002. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int. 89:449-453.
33. Kamai, T., T. Tsujii, K. Arai, K. Takagi, H. Asami, Y. Ito, and H. Oshima. 2003. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin. Cancer Res. 9:2632-2641.
34. Kamiyama, M., K. Utsunomiya, K. Taniguchi, T. Yokota, H. Kurata, N. Tajima, and K. Kondo. 2003. Contribution of Rho A and Rho kinase to platelet-derived growth factor-BB-induced proliferation of vascular smooth muscle cells. J. Atheroscler. Thromb. 10:117-123.
35. Kanda, T., K. Hayashi, S. Wakino, K. Homma, K. Yoshioka, K. Hasegawa, N. Sugano, S. Tatematsu, I. Takamatsu, T. Mitsuhashi, and T. Saruta. 2005. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension 45:724-729.
36. Kaneko, K., K. Satoh, A. Masamune, A. Satoh, and T. Shimosegawa. 2002. Expression of ROCK-1 in human pancreatic cancer: its down-regulation by morpholino oligo antisense can reduce the migration of pancreatic cancer cells in vitro. Pancreas 24:251-257.
37. Kishore, R., G. Qin, C. Luedemann, E. Bord, A. Hanley, M. Silver, M. Gavin, D. Goukassian, and D. W. Losordo. 2005. The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-α-induced transcriptional repression of cyclin A. J. Clin. Investig. 115:1785-1796.
38. Kleer, C. G., K. L. van Golen, Y. Zhang, Z. F. Wu, M. A. Rubin, and S. D. Merajver. 2002. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. Am. J. Pathol. 160:579-584.
39. Landis, M. W., B. S. Pawlyk, T. Li, P. Sicinski, and P. W. Hinds. 2006. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis. Cancer Cell 9:13-22.
40. Kip1. J. Biol. Chem. 274:21926-21931.
41. Leung, T., X. Q. Chen, E. Manser, and L. Lim. 1996. The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16:5313-5327.
42. CIP1, cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21:1590-1599.
43. WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res. 56:31-35.
44. Liu, Y., Y. J. Suzuki, R. M. Day, and B. L. Fanburg. 2004. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin. Circ. Res. 95:579-586.
45. Mallat, Z., A. Gojova, V. Sauzeau, V. Brun, J. S. Silvestre, B. Esposito, R. Merval, H. Groux, G. Loirand, and A. Tedgui. 2003. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice. Circ. Res. 93:884-888.
46. McMullan, R., S. Lax, V. H. Robertson, D. J. Radford, S. Broad, F. M. Watt, A. Rowles, D. R. Croft, M. F. Olson, and N. A. Hotchin. 2003. Keratinocyte differentiation is regulated by the Rho and ROCK signaling pathway. Curr. Biol. 13:2185-2189.
47. Montagnoli, A., F. Fiore, E. Eytan, A. C. Carrano, G. F. Draetta, A. Hershko, and M. Pagano. 1999. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 13:1181-1189.
48. Nishimaki, H., K. Kasai, K. Kozaki, T. Takeo, H. Ikeda, S. Saga, M. Nitta, and G. Itoh. 2004. A role of activated Sonic hedgehog signaling for the cellular proliferation of oral squamous cell carcinoma cell line. Biochem. Biophys. Res. Commun. 314:313-320.
49. 1. Science 269:1270-1272.
50. Waf1/Cip1. Nature 394: 295-299.
51. Perona, R., P. Esteve, B. Jimenez, R. P. Ballestero, S. Ramon y Cajal, and J. C. Lacal. 1993. Tumorigenic activity of rho genes from Aplysia californica. Oncogene 8:1285-1292.
52. Porter, K. E., N. A. Turner, D. J. O'Regan, A. J. Balmforth, and S. G. Ball. 2004. Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc. Res. 61:745-755.
53. Rees, R. W., N. A. Foxwell, D. J. Ralph, P. D. Kell, S. Moncada, and S. Cellek. 2003. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells. J. Urol. 170:2517-2522.
54. Ridley, A. J., and A. Hall. 1992. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70:389-399.
55. Riento, K., and A. J. Ridley. 2003. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell. Biol. 4:446-456.
56. Rivard, N., M. J. Boucher, C. Asselin, and G. L'Allemain. 1999. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells. Am. J. Physiol. 277:C652-C664.
57. 1 phase cyclin-dependent kinases. Mol. Cell. Biol. 23:4283-4294.
58. Roovers, K., E. A. Klein, P. Castagnino, and R. K. Assoian. 2003. Nuclear translocation of LIM kinase mediates Rho-Rho kinase regulation of cyclin D1 expression. Dev. Cell 5:273-284.
59. Sahai, E., T. Ishizaki, S. Narumiya, and R. Treisman. 1999. Transformation mediated by RhoA requires activity of ROCK kinases. Curr. Biol. 9:136-145.
60. Sahai, E., and C. J. Marshall. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer 2:133-142.
61. Sahai, E., M. F. Olson, and C. J. Marshall. 2001. Cross-talk between Ras and Rho signaling pathways in transformation favours proliferation and increased motility. EMBO J. 20:755-766.
62. Sampath, P., and T. D. Pollard. 1991. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 30:1973-1980.
63. Sauzeau, V., E. Le Mellionnec, J. Bertoglio, E. Scalbert, P. Pacaud, and G. Loirand. 2001. Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ. Res. 88:1102-1104.
64. Sawada, N., H. Itoh, K. Ueyama, J. Yamashita, K. Doi, T. H. Chun, M. Inoue, K. Masatsugu, T. Saito, Y. Fukunaga, S. Sakaguchi, H. Arai, N. Ohno, M. Komeda, and K. Nakao. 2000. Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101:2030-2033.
65. Seasholtz, T. M., M. Majumdar, D. D. Kaplan, and J. H. Brown. 1999. Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ. Res. 84:1186-1193.
66. KipI expression: role of RhoA. J. Am. Soc. Nephrol. 15:3026-3034.
67. Sherr, C. J. 2000. The Pezcoller lecture: cancer cell cycles revisited. Cancer Res. 60:3689-3695.
68. Sorensen, S. D., O. Nicole, R. D. Peavy, L. M. Montoya, C. J. Lee, T. J. Murphy, S. F. Traynelis, and J. R. Hepler. 2003. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes. Mol. Pharmacol. 64:1199-1209.
69. Spector, I., N. R. Shochet, Y. Kashman, and A. Groweiss. 1983. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 219:493-495.
70. Spence, H. J., L. McGarry, C. S. Chew, N. O. Carragher, L. A. Scott-Carragher, Z. Yuan, D. R. Croft, M. F. Olson, M. Frame, and B. W. Ozanne. 2006. AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins. Mol. Cell. Biol. 26:1480-1495.
71. Swant, J. D., B. E. Rendon, M. Symons, and R. A. Mitchell. 2005. Rho GTPase-dependent signaling is required for macrophage migration inhibitory factor-mediated expression of cyclin D1. J. Biol. Chem. 280:23066-23072.
72. Tanaka, T., I. Tatsuno, Y. Noguchi, D. Uchida, T. Oeda, S. Narumiya, T. Yasuda, H. Higashi, M. Kitagawa, K. Nakayama, Y. Saito, and A. Hirai. 1998. Activation of cyclin-dependent kinase 2 (Cdk2) in growth-stimulated rat astrocytes. Geranylgeranylated Rho small GTPase(s) are essential for the induction of cyclin E gene expression. J. Biol. Chem. 273:26772-26778.
73. Teramoto, H., R. L. Malek, B. Behbahani, M. D. Castellone, N. H. Lee, and J. S. Gutkind. 2003. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes. Oncogene 22:2689-2697.
74. Tharaux, P. L., R. C. Bukoski, P. N. Rocha, S. D. Crowley, P. Ruiz, C. Nataraj, D. N. Howell, K. Kaibuchi, R. F. Spurney, and T. M. Coffman. 2003. Rho kinase promotes alloimmune responses by regulating the proliferation and structure of T cells. J. Immunol. 171:96-105.
75. Uehata, M., T. Ishizaki, H. Satoh, T. Ono, T. Kawahara, T. Morishita, H. Tamakawa, K. Yamagami, J. Inui, M. Maekawa, and S. Narumiya. 1997. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389:990-994.
76. van Rossum, G. S. A. T., R. Klooster, H. van den Bosch, A. J. Verkleij, and J. Boonstra. 2001. Phosphorylation of p42/44MAPK by various signal transduction pathways activates cytosolic phospholipase A2 to variable degrees. J. Biol. Chem. 276:28976-28983.
77. Vichalkovski, A., K. Baltensperger, D. Thomann, and H. Porzig. 2005. Two different pathways link G-protein-coupled receptors with tyrosine kinases for the modulation of growth and survival in human hematopoietic progenitor cells. Cell Signal. 17:447-459.
78. Vidal, A., S. S. Millard, J. P. Miller, and A. Koff. 2002. Rho activity can alter the translation of p27 mRNA and is important for RasV12-induced transformation in a manner dependent on p27 status. J. Biol. Chem. 277:16433-16440.
79. Walker, K., and M. F. Olson. 2005. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr. Opin. Genet. Dev. 15:62-68.
80. Wang, G., A. Woods, S. Sabari, L. Pagnotta, L. A. Stanton, and F. Beier. 2004. RhoA/ROCK signaling suppresses hypertrophic chondrocyte differentiation. J. Biol. Chem. 279:13205-13214.
81. 1 progression through the independent regulation of cyclin D1 and p27. J. Biol. Chem. 272:32966-32971.
82. Weiss, R. H., E. A. Maga, and A. Ramirez. 1998. MEK inhibition augments Raf activity, but has variable effects on mitogenesis, in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 274:C1521-C1529.
83. 1 phase is controlled by Rho. Nat. Cell Biol. 3:950-957.
84. Woodrow, M. A., D. Woods, H. M. Cherwinski, D. Stokoe, and M. McMahon. 2003. Ras-induced serine phosphorylation of the focal adhesion protein paxillin is mediated by the Raf→MEK→ERK pathway. Exp. Cell Res. 287: 325-338.
85. 1 phase of the cell cycle. Oncogene 8:1449-1455.
86. Zhao, Z., and S. A. Rivkees. 2003. Rho-associated kinases play an essential role in cardiac morphogenesis and cardiomyocyte proliferation. Dev. Dyn. 226:24-32.
87. Zhou, J., L. Q. Zhao, M. M. Xiong, X. Q. Wang, G. R. Yang, Z. L. Qiu, M. Wu, and Z. H. Liu. 2003. Gene expression profiles at different stages of human esophageal squamous cell carcinoma. World J. Gastroenterol. 9:9-15.
88. Zhu, X.-H., H. Nguyen, H. D. Halicka, F. Traganos, and A. Koff. 2004. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover. Mol. Cell. Biol. 24:6058-6066.
89. Zugasti, O., W. Rul, P. Roux, C. Peyssonnaux, A. Eychene, T. F. Franke, P. Fort, and U. Hibner. 2001. Raf-MEK-Erk cascade in anoikis is controlled by Rac1 and Cdc42 via Akt. Mol. Cell. Mol. Cell. Biol. 21:6706-6717.